Author: bobby
Leen Kawas: The Barriers Women Face in Science—And How to Break Them
The story of women in science is often told in two parts: the remarkable breakthroughs and the quiet attrition. Names rise to prominence, but behind each one is a longer list of those who left the field—discouraged, sidelined, or simply exhausted. Leen Kawas has lived on both sides of that tension. As a scientist, entrepreneur,…
Read More
Personalized Medicine 101: How Genomics, Pharmacogenomics & Biomarkers Tailor Your Care
Personalized medicine is reshaping how health decisions are made by tailoring prevention, diagnosis, and treatment to the individual. Instead of a one-size-fits-all approach, this model uses biological data, lifestyle factors, and patient preferences to create care plans that improve outcomes and reduce unnecessary interventions. What personalized medicine looks likeAt its core, personalized medicine combines genomic…
Read More
De-Risking Biotech Startups: Funding, Regulatory Paths & Strategic Partnerships
Biotech startups face a unique blend of scientific risk, regulatory complexity, and capital intensity. Succeeding requires a mix of disciplined science, sharp business strategy, and the ability to move quickly while managing long timelines. This article distills practical guidance and current strategic trends that founders and investors are watching closely. Focus on a clear de-risking…
Read More
Navigating Digital Health Regulation and SaMD: A Practical, Risk-Based Guide for Regulatory Affairs Teams
Navigating digital health regulation: practical guidance for regulatory affairs teams Digital health products and software as a medical device (SaMD) present unique regulatory challenges that require a proactive, risk-based approach. Regulatory affairs teams must balance speed to market with robust evidence, cybersecurity, and ongoing surveillance to meet both national and international expectations. The following guidance…
Read More
Personalized Medicine: A Complete Guide to Genomic Testing, Pharmacogenomics, Benefits, and Ethical Challenges
Personalized medicine is reshaping how health care is delivered by tailoring prevention, diagnosis, and treatment to the individual. Instead of one-size-fits-all protocols, precision medicine uses a person’s genetic profile, lifestyle, environment, and biomarkers to guide decisions that improve outcomes and reduce unnecessary side effects. Key components of personalized medicine– Genomic testing: Sequencing and targeted genetic…
Read More
Precision Medicine Explained: How Personalized Genomic Care Is Transforming Health Decisions
Personalized Medicine: How Tailored Care Is Changing Health Decisions Personalized medicine—often called precision medicine—is reshaping how clinicians diagnose, treat, and prevent disease by tailoring decisions to the individual patient. At its core is the idea that genetic, environmental, and lifestyle differences matter; harnessing those differences leads to more effective, safer, and more efficient care. What…
Read More
Accelerating Drug Discovery: Structure-Led Design, Smarter Chemistry, and Predictive Models That Reduce Attrition
Drug discovery research is moving beyond traditional trial-and-error. A blend of improved structural insight, smarter chemistry, advanced biological models, and better data tools is shortening timelines and improving the odds that early candidates become safe, effective medicines. Target identification and validationThe foundation of any successful program is a well-validated target. Researchers increasingly combine genetic perturbation…
Read More
Personalized Medicine Explained: Genomic Testing, Pharmacogenomics, Digital Health, and Practical Steps for Patients and Clinicians
Personalized medicine is changing how clinicians prevent, diagnose, and treat disease by tailoring care to an individual’s genetics, lifestyle, and environment. This shift from one-size-fits-all approaches to more precise strategies can improve outcomes, reduce side effects, and help patients make informed choices about their health. Why personalized medicine mattersPersonalized medicine uses tools such as genomic…
Read More
Pharma Manufacturing: Embrace Continuous Processing and Digital Quality
Pharmaceutical manufacturing is evolving rapidly as companies balance speed, quality, and resilience. Meeting patient needs while satisfying stringent regulatory expectations requires a mix of technology, process design, and supply chain agility. Manufacturers that align operational changes with robust quality frameworks gain measurable advantages: faster time to market, lower batch failures, and improved sustainability. Key technological…
Read More
Regulator-Grade Real-World Evidence: 8 Essential Steps for Regulatory Teams to Accelerate Approvals
Real-world evidence (RWE) is reshaping regulatory affairs, offering a powerful complement to traditional clinical trial data. When generated and used correctly, real-world data (RWD) can accelerate approvals, support label expansions, improve safety monitoring, and strengthen market access arguments. For regulatory teams, turning RWD into robust RWE requires clear strategy, rigorous methods, and early engagement with…
Read More